Your shopping cart is currently empty

(S)-Gossypol acetic acid ((S)-(+)-Gossypol acetic acid) is a conformational isomer of Gossypol that acts as a BH3 mimic capable of binding Bcl-xL and Bcl-2 proteins, with the potential to induce apoptosis and inhibit cell growth.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $33 | - | In Stock | |
| 10 mg | $89 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $109 | - | In Stock |
| Description | (S)-Gossypol acetic acid ((S)-(+)-Gossypol acetic acid) is a conformational isomer of Gossypol that acts as a BH3 mimic capable of binding Bcl-xL and Bcl-2 proteins, with the potential to induce apoptosis and inhibit cell growth. |
| In vitro | (S)-Gossypol acetic acid inhibits proliferation and induces apoptosis in human nasopharyngeal carcinoma CNE-2 cells in a dose-dependent manner (2.5-20 μM, 24 h). (S)-Gossypol acetic acid decreases mitochondrial membrane potential, upregulates Bax, downregulates Bcl-2, and activates caspase-3[1]. |
| In vivo | In BALB/c nude mice bearing CNE-2 xenograft tumors, intraperitoneal administration of (S)-Gossypol acetic acid at 20 mg/kg/day for 21 days significantly inhibited tumor growth (~60% reduction in volume) without notable weight loss or systemic toxicity[1]. |
| Synonyms | (S)-(+)-Gossypol acetic acid |
| Molecular Weight | 578.61 |
| Formula | C32H34O10 |
| Cas No. | 1189561-66-7 |
| Smiles | O=CC1=C(O)C(O)=C(C2=CC(=C(C(O)=C12)C3=C(O)C4=C(C=O)C(O)=C(O)C(=C4C=C3C)C(C)C)C)C(C)C.O=C(O)C |
| Relative Density. | no data available |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 40 mg/mL (69.13 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble) | ||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (3.46 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.